- This event has passed.
Harm Reduction Psychotherapy & Psychedelics [ONLINE]
November 12 @ 12:00 pm - 1:30 pm
by Zendo Project (MAPS)
Harm Reduction Psychotherapy & Psychedelics:
An Integrative Approach to Addiction Treatment
Featuring Andrew Tatarksy, Ph.D., & Juliana Mulligan, moderated by Sara Gael, M.A.
Harm reduction psychotherapy is addiction therapy from a harm reduction standpoint, which seeks to focus on de-stigmatizing drug use and comparisons of moderation versus abstinence-only models. In this webinar session, we will explore how harm reduction experts advocate for safer use of psychedelics and other substances while holding space for a variety of approaches to drug use.
Juliana Mulligan has been an active member of the Ibogaine community for eight years and holds a B.A. in Psychology. She has worked in three Ibogaine clinics, completed Andrew Tatarsky’s IHRP training, and has presented at multiple Psychedelic and Harm Reduction conferences. Under her current business Inner Vision Ibogaine, she works therapeutically with people supporting them in preparation for, and in integration after, treatment. Previously Juliana was an opioid dependent person and in 2011, with the help of Ibogaine treatment, she left opioids behind and set off on a path to transform the way drug users and their treatment is approached.Her work centers around guiding individuals to their own inner power and supporting them in re-framing their life experiences into sources of knowledge and inspiration. She has developed a guide for finding safe Ibogaine treatment and is also currently working to create new systems of accountability and responsibility among Ibogaine practitioners and in the greater psychedelic therapy community. Juliana hopes to orient her work to focus on the social-cultural intersections of harm reduction and psychedelics. She has been featured in Double Blind magazine, Woman’s Day magazine, and Psymposia.
Andrew Tatarksy, Ph.D.
Dr. Andrew Tatarsky is a psychologist who developed Integrative Harm Reduction Psychotherapy (IHRP) for treating the spectrum of risky and addictive behavior. IHRP brings psychoanalysis, CBT and mindfulness together in a harm reduction frame. The therapy has been described in his book, Harm Reduction Psychotherapy: A New Treatment for Drug and Alcohol Problems, and a series of papers. The book has been translated into Polish and Spanish.He holds a doctorate in clinical psychology from the City University of New York and is a graduate of New York University’s Postdoctoral Program in Psychoanalysis and Psychotherapy. He is Founder and Director of the Center for Optimal Living in NYC, a treatment and training center; founding member and Past-President, Division on Addiction of New York State Psychological Association, and Member of the Medical and Clinical Advisory Boards of the New York State Office of Alcoholism and Substance Abuse Services. Dr. Tatarsky trains nationally and internationally.
Sara Gael, M.A.
Harm Reduction Officer, MAPS Zendo Project
Sara received her master’s degree in Transpersonal Counseling Psychology at Naropa University. She began working with MAPS in 2012, coordinating psychedelic harm reduction services at festivals and events worldwide with the Zendo Project. She served as the Director of Harm Reduction at MAPS from 2017-2020. Sara continues to train individuals and organizations in principles of psychedelic peer support. She is a therapist for the MAPS clinical trials of MDMA-assisted psychotherapy for PTSD in Boulder. She maintains a private practice as a psychotherapist specializing in trauma and psychedelic integration.She has presented at conferences, universities, and events around the world. She serves on the board of directors at DanceSafe and as the harm reduction advocate on the city of Denver psilocybin policy review panel. Sara believes that developing a comprehensive understanding of psychedelic medicines through research and education is essential for the health and well-being of individuals, communities, and the planet.